Thermo Fisher Scientific and Hamilton Partner to Offer Storage Solutions
|
By LabMedica International staff writers Posted on 09 Nov 2016 |

Image: The Decapper 500 and 550 systems are designed for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories (Photo courtesy of Business Wire).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) and Hamilton Storage (Reno, NV, USA) have entered into a partnership to offer the fully automated Thermo Scientific Decapper 500 and 550 Series tube capping systems for researchers seeking to streamline their sample storage processes.
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Latest Industry News
- QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026
- Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring
- Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections
- Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test
- GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR
- Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
- Takara Bio USA and Hamilton Partner to Automate NGS Library Preparation
- Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
- Integrated DNA Technologies Expands into Clinical Diagnostics
- Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
- Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
- New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network
- MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition
- Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical
- Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss
- QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
Channels
Clinical Chemistry
view channel
Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms
Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more
Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy
Routine blood tests that measure low-density lipoprotein (LDL), commonly known as “bad” cholesterol, are widely used to guide lipid-lowering therapy, but they do not always provide a complete picture of... Read more
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Cardiovascular diseases are a leading cause of death, responsible for nearly 20 million deaths each year. Timely triage of myocardial infarction and heart failure hinges on rapid cardiac biomarker measurement,... Read moreNext Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read moreMolecular Diagnostics
view channel
Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring
Osteosarcoma is a rare but aggressive pediatric bone cancer where recurrence and metastasis remain difficult to detect early. Imaging-based surveillance can miss small lesions and exposes children to repeated... Read more
Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk
Epstein–Barr virus (EBV) infects more than 95% of adults worldwide, yet only a small fraction develops EBV‑associated cancers such as nasopharyngeal carcinoma. Explaining this divergence requires understanding... Read moreHematology
view channel
Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read moreImmunology
view channel
Study Finds Influenza Often Undiagnosed in Winter Deaths
Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read moreCombined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read moreMicrobiology
view channelRapid Color Test Stratifies Virulent and Resistant Staph Strains
Staphylococcus aureus (golden staph) remains a leading cause of infection-related mortality worldwide, responsible for more than a million deaths each year. Rapidly distinguishing highly virulent or a... Read more
Syndromic Panel Enables Rapid Identification of Bloodstream Infections
Bloodstream infections require rapid identification of causative pathogens and resistance determinants to guide therapy, yet laboratories often face pressure to deliver clinically relevant results quickly... Read more
RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
Human skin carries diverse microbial communities that influence barrier function and inflammation, yet identifying which organisms are metabolically active has been challenging. DNA-based surveys catalog... Read more
Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots
Intensive care units face persistent threats from hospital-acquired infections, increasingly driven by drug-resistant bacteria. Rapidly pinpointing environmental reservoirs and transmission hotspots remains... Read morePathology
view channel
Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer
Colorectal cancer is common and often lethal, and therapeutic decision-making is complicated by heterogeneous tumor microenvironments. Immunotherapy benefits only a small subset of patients, around 5%,... Read more
Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugates
Antibody-drug conjugates (ADC) are reshaping oncology, yet scalable biomarkers that reliably predict which patients will benefit remain limited as treatment regimens and combinations grow more complex.... Read moreTechnology
view channel
AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Clinicians need reliable ways to identify likely responders before... Read more







